FDA Warning Letter — Linghai ZhanWang Biotechnology Co., Ltd

Case 697983 — FEI 3015248821

The FDA took a Warning Letter action against Linghai ZhanWang Biotechnology Co., Ltd on Feb 25, 2025 (Jinzhou, China). The action was issued by CDER and concerns drugs products.

Action Details

Facility
Linghai ZhanWang Biotechnology Co., Ltd
Date
Feb 25, 2025
Fiscal Year
2025
Product Type
Drugs
Center
CDER
Location
Jinzhou (China)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.